XML 21 R10.htm IDEA: XBRL DOCUMENT v3.8.0.1
Cash and Cash Equivalents and Investments
9 Months Ended
Sep. 30, 2017
Cash and Cash Equivalents and Investments [Abstract]  
Cash and Cash Equivalents Disclosure
Cash and Cash Equivalents and Investments
 
The fair value of cash and cash equivalents and investments held at September 30, 2017 and December 31, 2016 are as follows: 
 
 
As of September 30, 2017
 
 
Amortized Cost
 
Gross Unrealized Gains
 
Gross Unrealized Losses
 
Estimated Fair Value
 
 
(in thousands)
Cash and cash equivalents
 
$
83,293

 
$

 
$

 
$
83,293

Securities maturing within one year:
 
 
 
 
 
 
 
 
U.S. treasury securities
 
90,533

 

 
(57
)
 
90,476

Corporate debt securities
 
23,054

 

 
(6
)
 
23,048

Total short-term investments
 
$
113,587

 
$

 
$
(63
)
 
$
113,524

Total cash and cash equivalents and investments
 
$
196,880

 
$

 
$
(63
)
 
$
196,817

 
 
 
 
 
 
 
 
 
 
 
As of December 31, 2016
 
 
Amortized Cost
 
Gross Unrealized Gains
 
Gross Unrealized Losses
 
Estimated Fair Value
 
 
 
 
(in thousands)
 
 
Cash and cash equivalents
 
$
46,600

 
$

 
$

 
$
46,600

Securities maturing within one year:
 
 
 
 
 
 
 
 
U.S. treasury securities
 
227,911

 
1

 
(107
)
 
227,805

Corporate debt securities
 
72,188

 
1

 
(90
)
 
72,099

Total short-term investments
 
$
300,099

 
$
2

 
$
(197
)
 
$
299,904

Total cash and cash equivalents and investments
 
$
346,699

 
$
2

 
$
(197
)
 
$
346,504



There were $7,000 in realized losses for the nine months ended September 30, 2017, and no realized gains or losses for the nine months ended September 30, 2016. The cost of securities sold is based on the specific identification method.